LLY

1,046.75

+2.45%↑

JNJ

244.3

+1.63%↑

ABBV

225.77

+2.42%↑

NVS

161.26

+0.89%↑

MRK

120.13

+1.37%↑

LLY

1,046.75

+2.45%↑

JNJ

244.3

+1.63%↑

ABBV

225.77

+2.42%↑

NVS

161.26

+0.89%↑

MRK

120.13

+1.37%↑

LLY

1,046.75

+2.45%↑

JNJ

244.3

+1.63%↑

ABBV

225.77

+2.42%↑

NVS

161.26

+0.89%↑

MRK

120.13

+1.37%↑

LLY

1,046.75

+2.45%↑

JNJ

244.3

+1.63%↑

ABBV

225.77

+2.42%↑

NVS

161.26

+0.89%↑

MRK

120.13

+1.37%↑

LLY

1,046.75

+2.45%↑

JNJ

244.3

+1.63%↑

ABBV

225.77

+2.42%↑

NVS

161.26

+0.89%↑

MRK

120.13

+1.37%↑

Search

Zimmer Biomet Holdings Inc

Abierto

SectorSalud

95.11 0.36

Resumen

Variación precio

24h

Actual

Mínimo

94.47

Máximo

97.12

Métricas clave

By Trading Economics

Ingresos

78M

231M

Ventas

-76M

2B

P/B

Media del Sector

22.266

121.746

BPA

1.9

Rentabilidad por dividendo

1.07

Margen de beneficio

11.552

Empleados

17,000

EBITDA

63M

638M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 meses

+12.7% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

1.07%

2.26%

Próximas Ganancias

4 may 2026

Fecha Próximo Dividendo

29 abr 2026

Próxima Fecha de Ex Dividendo

30 mar 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-2B

18B

Apertura anterior

94.75

Cierre anterior

95.11

Noticias sobre sentimiento de mercado

By Acuity

39%

61%

113 / 352 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

Zimmer Biomet Holdings Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

5 nov 2025, 19:38 UTC

Ganancias

This Healthcare Stock Is the Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

5 nov 2025, 17:00 UTC

Ganancias

This Healthcare Stock Is Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

Comparación entre iguales

Cambio de precio

Zimmer Biomet Holdings Inc Esperado

Precio Objetivo

By TipRanks

12.7% repunte

Estimación a 12 meses

Media 101.13 USD  12.7%

Máximo 120 USD

Mínimo 88 USD

De acuerdo con 18 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Zimmer Biomet Holdings Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

18 ratings

5

Comprar

11

Mantener

2

Vender

Puntuación técnica

By Trading Central

92.27 / 100.88Soporte y Resistencia

Corto Plazo

Very Strong Bearish Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Strong Bearish Evidence

Sentimiento

By Acuity

113 / 352 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.
help-icon Live chat